Small, strong and enduring, and completing the Straumann portfolio for narrow space indications, the Ø 2.9mm implant brings all the Bone Level Tapered (BLT) advantages to narrow interdental spaces.
The Straumann Bone Level Tapered (BLT) Ø 2.9mm implant is the implant solution for narrow interdental spaces or ridges. The smallest in the Bone Level Tapered range, it completes the portfolio for narrow space indications and integrates seamlessly with the reliable Straumann® Dental Implant System.

Benefitting from the clinically-proven BLT design, it has a parallel body with full-depth thread and three cutting notches for self-cutting in underprepared sites. Its apically tapered design delivers excellent primary stability in soft bone and fresh extraction sockets as it adequately compresses the underprepared osteotomy and allows the clinician to effectively master the patient’s anatomy, even when limited, and protects the anatomical structure with its round tip.
As well as the tapered implant body, all Straumann BLT implants possess the powerful combination of Roxolid®, SLActive®, Bone Control Design™, CrossFit® connection and prosthetic diversity.
Roxolid®
Roxolid has enabled Straumann to create smaller implants than ever before, thus reducing invasiveness, by preserving bone and minimising the amount of bone grafting required. Roxolid is a high performance alloy, specifically designed to offer higher strength than pure titanium, making these smaller implants possible. Smaller implants increase the range of treatment options available to the clinician and patient acceptance will be higher when less invasive treatment options are offered.
SLActive®
The SLActive surface allows fast and predictable osseointegration, enabling safer and faster treatment and higher treatment predictability in challenging protocols. Clinically proven to provide safer and faster treatment in 3-4 weeks for all indications, it increases safety during the early healing phase and leads to a superior structural and functional connection between the implant and vital bone.
Bone Control Design™ and CrossFit® connections
Bone Control Design optimises crestal bone preservation while the CrossFit connections simplify handling and increase confidence in component positioning, ensuring precision against rotation and long-term flexibility.
Prosthetic diversity is ensured by compatibility with the full range of Straumann prosthetic components, including the unique oval design for optimal soft tissue management in smaller spaces.
The BLT Ø 2.9mm implant is indicated for single-tooth restorations of the central and lateral incisors in the mandible, and lateral incisors in the maxilla.
And coming soon… single use instruments will allow you to place the BLT Ø 2.9mm implant with sterile, disposable burs, drills, taps and profilers, ensuring your instruments are always sharp and minimising the cost and inconvenience of sterilisation.
For more information on the range of Straumann® Bone Level Tapered Implant solutions, please contact Straumann on 01293 651230 or visit straumann.co.uk.
Facebook: Straumann UK
Twitter: @StraumannUK
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/

GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.